Ticker

OWLT's fourth-quarter results are likely to reflect subscription growth, FDA-backed differentiation and revenue gains, even as tariff pressures weigh on margins.

Shares of Owlet, Inc. (NYSE: OWLT - Get Free Report) have earned a consensus rating of "Moderate Buy" from the five analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, three have assigned a buy rating and one has issued a strong buy rating on

LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced it has selected Hannah Cranston Media (HCM) as its public relations agency of record (AOR). Following a competitive review, Owlet selected HCM for its expertise in health tech, wellness, and consumer innovation, and its demonstrated ability to position…

LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026. Owlet's President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m.…

For the quarter ended December 31, 2025, the fund returned 3.77% (Class I shares at NAV), outperforming the Russell 2000 Growth Index return of 1.22%. Lumentum's stock strength in Q4 2025 was driven by a clean earnings beat and accelerating momentum in AI-related optical demand. Stride's common stock declined -56% for the quarter, dropping significantly after the earnings release, even as the company beat EPS and…